It is a pharma private limited company based in Pune, Maharashtra, India, established in 2020.
2020 | Pune, Maharashtra, India | ActiveLi Shanto Pharmaceuticals Private Limited, a active private limited company, was established on 24 August 2020 in Pune, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24304PN2020PTC193291. Registered under ROC Roc Pune. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.10 M.
Its leadership includes Sanjeev Kumar (Director), Birendra Kumar Singh (Managing Director), Vikash Kumar Singh (Director). Past directors included Sanjeev Kumar. It holds ₹5.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at S. No. 5/4, F. No. 604B, Tara Angan, Keshav Nagar,Pune,Maharastra-411036, Pune, Maharashtra, 411036.
U24304PN2020PTC193291
193291
24 August 2020
₹1.00 M
₹0.10 M
Roc Pune
Unlisted
Active
Explore comprehensive insights into Li Shanto Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sanjeev Kumar | Director | 24 Aug 2020 | Current |
| Birendra Kumar Singh | Managing Director | 24 Aug 2020 | Current |
| Vikash Kumar Singh | Director | 24 Aug 2020 | Current |
| Akash Kumar | Director | 24 Aug 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | - | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Li Shanto Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1885.7% increase. The company also saw a substantial improvement in profitability, with a 288.87% increase in profit. The company's net worth Soared by an impressive increase of 66.93%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Li Shanto Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹5,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Feb 2022 | Canara Bank | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Li Shanto Pharmaceuticals has a workforce of 0 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Li Shanto Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Li Shanto Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Li Shanto Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Li Shanto Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Pune. was documented.
Progress on A charge with Canara Bank amounted to Rs. 5.00 M with Charge ID 100557479 was registered on 01 Feb 2022. was documented.
The activity Sanjeev Kumar was appointed as a Director was appointed as a Director on 24 Aug 2020 & has been associated with this company since 5 years 3 months . was completed.
Progress on Birendra Kumar Singh was appointed as a Managing Director was appointed as a Managing Director on 24 Aug 2020 & has been associated with this company since 5 years 3 months . was documented.
Vikash Kumar Singh was appointed as a Director was appointed as a Director on 24 Aug 2020 & has been associated with this company since 5 years 3 months . was recorded as a recent event.
The CIN of Li Shanto Pharmaceuticals Private Limited is U24304PN2020PTC193291.
Li Shanto Pharmaceuticals Private Limited is headquartered at S. No. 5/4, F. No. 604B, Tara Angan, Keshav Nagar,Pune,Maharastra-411036, Pune, Maharashtra, 411036.
Li Shanto Pharmaceuticals Private Limited was incorporated on 24 August 2020.
The current directors of Li Shanto Pharmaceuticals Private Limited are
The primary industry of Li Shanto Pharmaceuticals Private Limited is Manufacturing.
Li Shanto Pharmaceuticals Private Limited is unlisted.
The authorized capital of Li Shanto Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.10 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX